UsingofantibioticsinPatientswithTumor(3)
Bibliography：
[1]Zhen,Yongsu. Anti-tumor antibiotic and monoclonal antibody drug research progress[J]. Chinese Journal of Antibiotics. 2002，27(1)：1.
[2]Zhen,Yongsu. Microbial medicine and antibody drugs-- Important fields of discovery and development of new drugs[J]. Pharmaceutical journal, 2003，38(7)：483.
[3]Xu Y J, Zhen Y S, Goldberg I H. C1027 chromophore, a potent new enediyne antitumor antibiotic, induces sequencespecific doublestrand DNA cleavage [J]. Biochemistry,1994,33:5947.
[4]He Q Y, Liang Y Y, Wang D S, et al. Characteristics of mitotic cell death induced by enediyne antibiotic lidamycin in human epithelial tumor cells [J]. Int J Oncol,2002,20(2):261.
[5]Kawanishi S, Hiraku Y. Amplification of anticancer druginduced DNA damage and apoptosis by DNAbinding compounds [J]. Curr Med Chem AntiCancer Agents,2004,4(5):415.
[6]Wu J, Ling X, Pan D, et al. Molecular mechanism of inhibition of survivin transcription by the GCrich sequenceselective DNA binding antitumor agent, hedamycin: evidence of survivin downregulation associated with drug sensitivity [J]. J Biol Chem,2005,280(10):9745., http://www.100md.com(LIU Kun)
[1]Zhen,Yongsu. Anti-tumor antibiotic and monoclonal antibody drug research progress[J]. Chinese Journal of Antibiotics. 2002，27(1)：1.
[2]Zhen,Yongsu. Microbial medicine and antibody drugs-- Important fields of discovery and development of new drugs[J]. Pharmaceutical journal, 2003，38(7)：483.
[3]Xu Y J, Zhen Y S, Goldberg I H. C1027 chromophore, a potent new enediyne antitumor antibiotic, induces sequencespecific doublestrand DNA cleavage [J]. Biochemistry,1994,33:5947.
[4]He Q Y, Liang Y Y, Wang D S, et al. Characteristics of mitotic cell death induced by enediyne antibiotic lidamycin in human epithelial tumor cells [J]. Int J Oncol,2002,20(2):261.
[5]Kawanishi S, Hiraku Y. Amplification of anticancer druginduced DNA damage and apoptosis by DNAbinding compounds [J]. Curr Med Chem AntiCancer Agents,2004,4(5):415.
[6]Wu J, Ling X, Pan D, et al. Molecular mechanism of inhibition of survivin transcription by the GCrich sequenceselective DNA binding antitumor agent, hedamycin: evidence of survivin downregulation associated with drug sensitivity [J]. J Biol Chem,2005,280(10):9745., http://www.100md.com(LIU Kun)